Bioorganic and Medicinal Chemistry Letters p. 3123 - 3126 (1999)
Update date:2022-08-04
Topics:
Yoshida, Yoshiki
Matsuda, Keiji
Sasaki, Hiroshi
Matsumoto, Yoshimi
Matsumoto, Satoru
Takasugi, Hisashi
The synthesis and anti-Helicobacter pylori activity of a novel cephem derivative FR182024 (1) are described. FR182024 having a (5-methyl-1,3,4-thiadiazol-2-yl)-thio moiety at the 3-position and a phenylacetamido at the 7-position was found to have extremely potent in vitro anti-H.pylori activity, superior therapeutic efficacy to AMPC and CAM, and low potential for causing diarrhea.
View MoreContact:+86-512-56795332
Address:No227 Shuanglong Rd, Fenghuang, Zhangjiagang
Taizhou Green Peptide Trading Co., Ltd.
Contact:--15314709780
Address:Room 1501, No71, Yuehe Road, Taizhou City, Zhejiang Province, China
Jiangsu Zhenfang Chemical CO.,LTD.(Suzhou Zhenfang Chemical Factory)
Contact:+86-512-69598882
Address:Room1201, Jiayuan Road No.1018, Xiangcheng District, Suzhou, China
Huaian Double Win Chemicals Co.,Ltd.
Contact:+86-13511538872
Address:Blk 43,Greenland Century Town,Huaian District, Huaian City,Jiangsu Province,China
Shanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
Doi:10.1016/0031-9422(96)00242-7
(1996)Doi:10.1039/b912325c
(2009)Doi:10.1016/0020-1650(68)80164-3
(1968)Doi:10.1016/S0022-328X(96)87021-5
(1996)Doi:10.1007/BF00702025
()Doi:10.1039/dt9960002541
(1996)
